Company Description

The successful candidate will join the Emerging Viruses, Inflammation and Therapeutics (EVIT) Research Group. The group has an established international reputation for studying mosquito-borne viruses, particularly alphaviruses such as chikungunya and Ross River virus, with a strong focus on virus–host interactions, immunopathogenesis, therapeutics, and vaccine development. The EVIT group integrates multidisciplinary approaches spanning molecular virology, immunology, animal models, and translational research. Its work has contributed to the development of novel vaccine strategies and therapeutic interventions for emerging viral diseases, with strong links to industry and international collaborators. The team provides a highly collaborative and supportive research environment, with access to state-of-the-art facilities and strong national and international partnerships. The candidate will have opportunities to engage in interdisciplinary pro...